Movement Alert｜Elevance Health Falls 3.3% in Regular Trading, Reaffirmed Full-Year EPS Guidance Slightly Below Consensus

Market Focus06-10

On June 10, Elevance Health declined 3.3% in regular trading, trading at $407.54/share, with trading volume of $66.61 million.

On the news front, Elevance Health reaffirmed its full-year adjusted earnings guidance of at least $26.75 per diluted share in a regulatory filing, slightly below the FactSet analyst consensus estimate of $26.85. The company also confirmed GAAP diluted EPS guidance of no less than $19.85 for fiscal year 2026. While the shortfall versus consensus is modest at roughly $0.10, the lack of an upward revision disappointed investors seeking positive catalysts.

Sector-wide weakness compounded the selling pressure. Within the Managed Health Care industry, UnitedHealth fell 1.39%, Molina Healthcare dropped 4.33%, Centene declined 3.07%, and Humana lost 0.75%. Notably, JPMorgan recently raised its price target on Elevance Health from $411 to $476 maintaining an overweight rating, and Morgan Stanley lifted its target to $404, suggesting Wall Street maintains a constructive longer-term outlook despite the near-term guidance disappointment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197386088?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 21:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197386088","market":"us","top_or_hot":-1,"title":"Movement Alert｜Elevance Health Falls 3.3% in Regular Trading, Reaffirmed Full-Year EPS Guidance Slightly Below Consensus","media":"Market Focus","content":"<p><p>On June 10, Elevance Health declined 3.3% in regular trading, trading at $407.54/share, with trading volume of $66.61 million.</p><p>On the news front, Elevance Health reaffirmed its full-year adjusted earnings guidance of at least $26.75 per diluted share in a regulatory filing, slightly below the FactSet analyst consensus estimate of $26.85. The company also confirmed GAAP diluted EPS guidance of no less than $19.85 for fiscal year 2026. While the shortfall versus consensus is modest at roughly $0.10, the lack of an upward revision disappointed investors seeking positive catalysts.</p><p>Sector-wide weakness compounded the selling pressure. Within the Managed Health Care industry, UnitedHealth fell 1.39%, Molina Healthcare dropped 4.33%, Centene declined 3.07%, and Humana lost 0.75%. Notably, JPMorgan recently raised its price target on Elevance Health from $411 to $476 maintaining an overweight rating, and Morgan Stanley lifted its target to $404, suggesting Wall Street maintains a constructive longer-term outlook despite the near-term guidance disappointment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Elevance Health Falls 3.3% in Regular Trading, Reaffirmed Full-Year EPS Guidance Slightly Below Consensus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Elevance Health Falls 3.3% in Regular Trading, Reaffirmed Full-Year EPS Guidance Slightly Below Consensus\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-10 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 10, Elevance Health declined 3.3% in regular trading, trading at $407.54/share, with trading volume of $66.61 million.</p><p>On the news front, Elevance Health reaffirmed its full-year adjusted earnings guidance of at least $26.75 per diluted share in a regulatory filing, slightly below the FactSet analyst consensus estimate of $26.85. The company also confirmed GAAP diluted EPS guidance of no less than $19.85 for fiscal year 2026. While the shortfall versus consensus is modest at roughly $0.10, the lack of an upward revision disappointed investors seeking positive catalysts.</p><p>Sector-wide weakness compounded the selling pressure. Within the Managed Health Care industry, UnitedHealth fell 1.39%, Molina Healthcare dropped 4.33%, Centene declined 3.07%, and Humana lost 0.75%. Notably, JPMorgan recently raised its price target on Elevance Health from $411 to $476 maintaining an overweight rating, and Morgan Stanley lifted its target to $404, suggesting Wall Street maintains a constructive longer-term outlook despite the near-term guidance disappointment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"","article_id":"1197386088","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197386088","pubTimestamp":1781099339,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 10, Elevance Health declined 3.3% in regular trading, trading at $407.54/share, with trading volume of $66.61 million.On the news front, Elevance Health reaffirmed its full-year adjusted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"动向提示|Elevance Health常规交易下跌3.3%，重申全年EPS指引略低于市场预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"On June 10, Elevance Health declined 3.3% in regular trading, trading at $407.54/share, with trading volume of $66.61 million.On the news front, Elevance Health reaffirmed its full-year adjusted earnings guidance of at least $26.75 per diluted share in a regulatory filing, slightly below the FactSet analyst consensus estimate of $26.85. The company also confirmed GAAP diluted EPS guidance of no less than $19.85 for fiscal year 2026. While the shortfall versus consensus is modest at roughly $0.10, the lack of an upward revision disappointed investors seeking positive catalysts.Sector-wide weakness compounded the selling pressure. Within the Managed Health Care industry, UnitedHealth fell 1.39%, Molina Healthcare dropped 4.33%, Centene declined 3.07%, and Humana lost 0.75%. Notably, JPMorgan recently raised its price target on Elevance Health from $411 to $476 maintaining an overweight rating, and Morgan Stanley lifted its target to $404, suggesting Wall Street maintains a constructive longer-term outlook despite the near-term guidance disappointment.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197386088","isCrawlerRequest":true}